每经AI快讯，12月18日，江苏国信（002608）(002608.SZ)公告称，控股子公司国信扬电申报的国信扬 电三期2×100万千瓦扩建项目已于2025年6月获得项目核准。为推进项目建设，国信扬电拟引进两家新 股东，各股东方拟采用非公开协议方式，以非同比例增资形式对国信扬电增资18亿元，共同出资建设国 信扬电三期项目。其中江苏国信增资106,755万元、扬子江文旅不增资、泰州泰能增资9,000万元、扬州 市能源集团增资45,830万元、扬州市绿投集团增资18,415万元。增资完成后，各方在国信扬电所占股权 比例分别为：江苏国信75%、扬子江文旅2.56%、泰州泰能5%、扬州市能源集团12.44%、扬州市绿投集 团5%。 ...

2025年1至6月份，江苏国信的营业收入构成为：电力占比97.28%，金融占比2.72%。 每经AI快讯，江苏国信（SZ 002608，收盘价：7.74元）12月18日晚间发布公告称，为推进国信扬电三 期项目建设，国信扬电拟引进两个新股东方：扬州市能源投资发展集团有限公司和扬州绿色产业投资发 展控股（集团）有限责任公司。经协商，各股东方拟采取非公开协议方式，以评估价值为依据，按照非 同比例增资扩股方案对国信扬电增资18亿元，其中江苏国信增资约10.68亿元、扬子江文旅不增资、泰 州泰能增资9000万元、扬州市能源集团增资约4.58亿元、扬州市绿投集团增资约1.84亿元。增资完成 后，各方在国信扬电所占股权比例分别为：江苏国信75%、扬子江文旅2.56%、泰州泰能5%、扬州市能 源集团12.44%、扬州市绿投集团5%。 截至发稿，江苏国信市值为292亿元。 （记者 曾健辉） 每经头条（nbdtoutiao）——海南封关政策红利全解析：零关税、低个税、投资准入放宽、跨境资金自 由、创业扶持…… ...

证券代码：002608 证券简称：江苏国信 公告编号：2025-054 江苏国信股份有限公司 关于对子公司国信扬电增资的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 江苏国信股份有限公司（以下简称"公司"或"江苏国信"）控股子 公司江苏国信扬州发电有限责任公司（以下简称"国信扬电"）申报的 国信扬电三期 2×100 万千瓦扩建项目（以下简称"国信扬电三期项目"）， 已于 2025 年 6 月获得项目核准。为推进项目建设，国信扬电拟引进两 家新股东，各股东方拟采用非公开协议方式，以非同比例增资形式对国 信扬电增资扩股，共同出资建设国信扬电三期项目。具体情况如下： 一、对外投资概述 1. 国信扬电注册资本金 100,000 万元，江苏国信持股 90%；扬州市 扬子江文旅投资发展集团有限责任公司（以下简称"扬子江文旅"）持 股 5%；泰州市泰能投资管理有限责任公司（以下简称"泰州泰能"） 持股 5%。 2. 2025 年 12 月 18 日，公司召开第七届董事会第一次会议，全票 审议通过了《关于对子公司国信扬电增资的议案》。 3. 根据《深圳证券交易所股票上 ...

证券代码：002608 证券简称：江苏国信 公告编号：2025-053 江苏国信股份有限公司 关于董事会完成换届选举并聘任高级管理人员 一、第七届董事会组成情况 公司第七届董事会由 7 名董事组成，其中非独立董事 4 名，独立 董事 3 名。 及证券事务代表的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 江苏国信股份有限公司（以下简称"公司"）于 2025 年 12 月 18 日召开 2025 年第三次临时股东会，选举产生了第七届董事会成员。 同日，公司召开第七届董事会第一次会议，会议审议通过了选举公司 董事长、各专门委员会委员及聘任公司高级管理人员、证券事务代表 的议案。公司董事会换届完成，现将相关情况公告如下： 1.非独立董事：徐文进先生（董事长）、翟军先生、丁旭春先生、 宋才俊先生。 2.独立董事：温素彬先生、张洪发先生、张利军先生 公司第七届董事会成员均具备担任上市公司董事的任职资格，公 司第七届董事会成员任期三年，自公司 2025 年第三次临时股东会选 举通过之日起至第七届董事会届满之日止。公司第七届董事会成员中， 1 兼任公司高级管理人员以 ...

2025 年第三次临时股东会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 特别提示： 1. 本次股东会无增加、变更、否决议案的情况。 2. 本次股东会以现场书面表决与网络投票相结合的方式召开。 一、会议召开情况 证券代码：002608 证券简称：江苏国信 公告编号：2025-051 江苏国信股份有限公司 1. 会议召开时间： （1）现场会议时间：2025年12月18日（星期四）下午14:30召开。 现场会议召开地点：南京市玄武区长江路88号国信大厦会议厅。 （2）网络投票时间：2025年12月18日。其中，通过深圳证券交 易所交易系统进行网络投票的具体时间为2025年12月18日的交易时 间，即9:15-9:25，9:30-11:30和13:00-15:00；通过深圳证券交易所互联 网投票的具体时间为2025年12月18日09:15至15:00期间的任意时间。 2. 会议召集人：公司董事会 3. 会议召开方式：现场书面表决与网络投票相结合的方式 4. 会议主持人：董事长徐文进先生 5. 本次股东会的召集、召开与表决程序符合《公司法》等法律、 法规和 ...

江 苏 国 信 股 份 有 限 公 司 2025 年 第 三 次 临 时 股 东 会 的 法 律 意 见 书 dentons.cn 北 京 大 成 （ 南 京 ） 律 师 事 务 所 关 于 南京市鼓楼区集慧路 18 号联创大厦 A 座 7-11 层（210036） 18 Jihui Road, 7-11/F of Building A, Lianchuang Mansion, Gulou District,Nanjing,China,210036 Tel: +86-25-8375 5101 Fax: +86-25-8375 5005 dentons.cn 北京大成（南京）律师事务所 关于江苏国信股份有限公司 2025 年第三次临时股东会的法律意见书 致：江苏国信股份有限公司 根据《中华人民共和国证券法》（以下简称"《证券法》"）、《中华人民共和国公司 法》（以下简称"《公司法》"）和中国证券监督管理委员会《上市公司股东会规则》（以 下简称"《股东会规则》"）等法律、法规和其他有关规范性文件的要求，北京大成（南 京）律师事务所（以下简称"本所"）接受江苏国信股份有限公司（以下简称"公司"）的 委托，指派律师参 ...

本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 江苏国信股份有限公司（以下简称"公司"）第七届董事会第一 次会议通知于 2025 年 12 月 8 日，以书面、通讯方式发给公司董事， 会议于 2025 年 12 月 18 日在公司会议室以现场方式召开。本次会议 应出席董事七名，实际出席董事七名。本次会议的召开符合《公司法》 和《公司章程》的规定。经与会董事推选，本次会议由徐文进先生召 集并主持。与会董事经过认真审议，做出如下决议： 一、审议通过《关于选举公司第七届董事会董事长的议案》 选举徐文进先生为江苏国信股份有限公司第七届董事会董事长， 任期三年（自本次董事会会议审议通过之日起至本届董事会届满止）。 徐文进先生现任控股股东江苏省国信集团有限公司总经理，兼任我公 司董事长。 表决结果：7 票赞成，0 票反对，0 票弃权。 二、审议通过《关于选举公司第七届董事会专门委员会委员的议 案》 证券代码：002608 证券简称：江苏国信 公告编号：2025-052 江苏国信股份有限公司 第七届董事会第一次会议决议公告 1 为完善公司法人治理结构，公司设立第七届董事会专 ...

Group 1 - Moer Thread plans to use up to 7.5 billion yuan of idle raised funds for cash management, with a usage period of 12 months [1] - O-film plans to purchase 8.46% equity of its subsidiary Anhui Che Lian for a total of 3.64 billion yuan, increasing its ownership from 78.54% to 87% [2] - ST Lian Shi applies to revoke the delisting risk warning as its restructuring plan has been completed [3] Group 2 - Weirli signs a strategic cooperation framework agreement with Primech Holdings to build an industrial robot cooperation platform [4] - Race Intelligent plans to raise no more than 1.144 billion yuan through a private placement for core components of intelligent equipment [5] - Renfu Pharmaceutical's stock will be subject to other risk warnings and will be suspended for one day starting December 15 [6] Group 3 - Yongding Co. clarifies that its subsidiary Dongbu Superconductor does not directly manufacture controllable nuclear fusion devices [7] - Rongbai Technology plans to acquire part of Guizhou Xinren's equity and increase its capital to achieve control [9] - ST Hu Ke is under investigation by the Securities Regulatory Commission for suspected information disclosure violations [10] Group 4 - Yunnan Ge Industry plans to establish a subsidiary focused on organic germanium-related products [11] - Greenme intends to acquire 16.38% equity of Henan Recycling Group for 400 million yuan [12] - Jiangzhong Pharmaceutical plans to change its name to China Resources Jiangzhong Pharmaceutical [13] Group 5 - Jiangsu Guoxin's subsidiary Ma Zhou Power has completed the trial operation of a 1,000 MW coal-fired power generation unit [16] - Longsheng Technology plans to invest in a center for embodied intelligent robots [18] - Guangzhou Development has received approval for the registration of 8 billion yuan medium-term notes and 6 billion yuan short-term financing notes [19] Group 6 - China Merchants Port reported a container throughput of 17.248 million TEUs in November, a year-on-year increase of 6.4% [20] - Tianma Technology reported a total eel output of approximately 11,415.87 tons from January to November [21] Group 7 - Xilong Science plans to reduce its stake by up to 1% [22] - Xicet Testing's actual controller plans to transfer 5% of the company's shares [23] - Oppein Home's actual controller plans to increase its stake by 50 million to 100 million yuan [24] Group 8 - Maide Medical plans to repurchase shares worth 20 million to 40 million yuan [25] - Baicheng Pharmaceutical's major shareholder increased its stake by 0.85% [26] - Mengbaihe's major shareholder plans to reduce its stake by up to 1% [27] Group 9 - Xian Dao Ji Dian's shareholder has reduced its stake by 1.70% [28] - Yaxiang Integration's shareholder reduced its stake by 41,400 shares [29] - Zhiwei Intelligent's actual controller has reduced its stake, bringing the total holding to 69% [30] Group 10 - Jincheng Co.'s actual controller plans to reduce its stake by up to 0.97% [31] - Jianghua Micro's chairman has reduced his stake by 1.09% [32] - COSCO Shipping Energy signed a shipbuilding contract worth 7.882 billion yuan [33] Group 11 - Dayu Water Saving's subsidiary is expected to win two high-standard farmland construction projects [34] - Guorui Technology's subsidiary is a candidate for the GXLF project [36] - ST Zhisheng has won a smart city governance project worth 104 million yuan [37]

Group 1 - Shouyao Holdings is planning to issue H-shares and list on the Hong Kong Stock Exchange, with discussions ongoing with intermediaries regarding the specifics of the listing [1] - Jiangsu Guoxin's subsidiary, Guoxin Mazhou, has completed the trial operation of a 1000MW coal-fired power unit, which is set to officially commence operations on December 12, 2025 [2] - Yuekang Pharmaceutical's mRNA tumor vaccine has received clinical trial approval from the National Medical Products Administration for treating advanced solid tumors [3] Group 2 - Dongli New Science plans to invest 666 million yuan in the restructuring of SAIC Hongyan, acquiring approximately 14.66% equity post-restructuring [4] - Longsheng Technology is set to invest approximately 350 million yuan in the establishment of an intelligent robot innovation center in Wuxi [5] - Shangwei Co. has received a government subsidy of 2.212 million yuan, which accounts for 13.53% of its audited net profit for 2024 [6] Group 3 - Anglikang has received drug registration certificates for Diclofenac Sodium Enteric-Coated Tablets and approval for a supplemental application for Sacubitril/Valsartan Sodium Tablets [7] - Guangzhou Development has received acceptance notices for the registration of 8 billion yuan in medium-term notes and 6 billion yuan in short-term financing bonds [8] - Kebo Da plans to increase capital by 21.2 million euros (approximately 174 million yuan) in its wholly-owned subsidiary in Germany [9][10] Group 4 - Changguang Huaxin has received a total of 11.6672 million yuan in government subsidies, including 8.0552 million yuan related to income [11] - Haizheng Pharmaceutical's subsidiary has received a European Pharmacopoeia suitability certificate for its raw material [12] - Qianjin Pharmaceutical's subsidiary has received a drug registration certificate for Lurasidone Hydrochloride Tablets, used for treating schizophrenia [13] Group 5 - Daimai Co. has received a warning letter from the Shanghai Securities Regulatory Bureau due to failure to timely disclose a significant event related to a fire incident [14] - ST Changyao's subsidiary has recently ceased production due to financial difficulties and competitive pressures in the photovoltaic industry [15] - Guodian Power is investing in the construction of a 2×1000MW expansion project at the Ganbi Power Plant, with a total dynamic investment of 7.218 billion yuan [16] Group 6 - Kaichuang International's subsidiary has completed the handover of a tuna purse seine vessel, expected to be operational by 2026 [16] - Tieke Rail plans to sign an energy management agreement for a distributed photovoltaic project, which is expected to save approximately 1.441 million yuan in electricity costs over 25 years [18] - Bailian Co. plans to sign a land compensation agreement with Friendship Logistics, with a total compensation of 103 million yuan [19] Group 7 - Dayu Water-saving's subsidiary has been pre-awarded two high-standard farmland construction projects, with total expected amounts of 137 million yuan and 135 million yuan respectively [20] - Tianma Technology reported a total eel output of approximately 1197.15 tons in November, with sales prices ranging from 53,000 yuan/ton to 89,000 yuan/ton [21] - Guorui Technology's subsidiary has been shortlisted for the GXLF project with a bid of 76 million yuan [22] Group 8 - Qingdao Food's deputy general manager has resigned for personal reasons [23] - Guosheng Zhike plans to use up to 900 million yuan of idle funds for cash management [24] - Guodian Nanrui plans to use up to 23 billion yuan of idle funds for entrusted wealth management [25] Group 9 - Jiahuan Energy plans to merge its wholly-owned subsidiary, Zhejiang Jiahuan Hydrogen Peroxide Co., Ltd., through an overall absorption merger [26] - Ganyue Expressway reported vehicle toll service revenue of 309 million yuan for November [27] - Jinling Hotel's chairman has resigned due to work changes [28] Group 10 - Lisheng Pharmaceutical's subsidiary has received drug registration certificates for Apremilast Tablets [29] - Baotai has received a positive opinion from the European Medicines Agency for Gotenfia® for various inflammatory conditions [30] - ST Zhisheng has been awarded a smart city governance project with a bid amount of 104 million yuan [31] Group 11 - Chenxi Aviation and its related personnel have received administrative regulatory measures from the Shaanxi Securities Regulatory Bureau due to financial reporting issues [32] - Portong Medical has appointed Xia Canglan as the new deputy general manager [33] - Maide Medical plans to repurchase shares with a total amount between 20 million and 40 million yuan [34] Group 12 - Jimin Health plans to establish a joint venture with a total investment of 600 million yuan, focusing on AI and software development [35] - Beilu Pharmaceutical has received a drug registration certificate for Pioglitazone Metformin Tablets [36] - Hainan Mining plans to entrust the overall management of the Shiluo Iron Mine to a construction company for three years, with a total contract amount of approximately 818 million yuan [38] Group 13 - Huiyu Pharmaceutical has received a drug registration certificate for Nicardipine Hydrochloride Injection [39] - Baoland has received a government subsidy of 10 million yuan related to income [40] - Qingdao Port has terminated the acquisition of 100% equity in an oil company and 50% equity in Rizhao Shihua due to regulatory concerns [41]

股票频道更多独家策划、专家专栏，免费查阅>> 责任编辑：山上 格隆汇12月12日丨江苏国信(002608.SZ)公布，公司控股子公司江苏国信马洲发电有限公司（以下简 称"国信马洲"）新建的一台1000MW二次再热超超临界燃煤发电机组，完成168小时满负荷试运行，于 2025年12月12日正式投产运营。 此次投产的国信马洲100万千瓦机组选用先进的二次再热、超超临界技术，机组能源利用率高，各排放 指标实现超低排放；创新融合煤电机组熔盐储能系统，可高效灵活响应新型电力系统的调节需求。该机 组投产后将填补江苏省"十五五"期间电力供应缺口，进一步优化区域电力结构。 ...